Otsuka (OTCMKTS:OTSKY) Shares Up 8.9% – Here’s Why

Shares of Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY) rose 8.9% during trading on Friday . The company traded as high as $34.9288 and last traded at $34.9288. Approximately 489 shares traded hands during mid-day trading, a decline of 99% from the average daily volume of 34,671 shares. The stock had previously closed at $32.07.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on OTSKY. Zacks Research lowered Otsuka from a “strong-buy” rating to a “hold” rating in a research report on Friday, January 30th. UBS Group raised Otsuka to a “hold” rating in a research report on Tuesday, January 27th. Finally, Morgan Stanley upgraded shares of Otsuka to an “overweight” rating in a report on Friday, January 23rd. One investment analyst has rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold”.

Otsuka Stock Up 7.9%

The business has a fifty day moving average price of $29.48 and a two-hundred day moving average price of $27.93.

Otsuka Company Profile

Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.

Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.